Revance Therapeutics, Inc. Business Finance Contracts & Agreements

34 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Supplemental Indenture, by and among Revance Therapeutics, Inc. and U.S. Bank Trust Company, National Association, dated as of February 6, 2025
Indenture Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2025
Underwriting Agreement, dated March 4, 2024, by and between the Company and the Underwriter
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2024
Form of Restricted Stock Unit Agreement and Grant Notice under Amended and Restated Revance Therapeutics, Inc. 2014 Inducement Plan
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2023
Underwriting Agreement, dated September 12, 2022, by and among the Company and the Underwriters
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2022
Note Purchase Agreement dated March 18, 2022 among Revance Therapeutics, Inc., certain subsidiaries of Revance Therapeutics, Inc., Athyrium Buffalo LP and the purchasers from time...
Note Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2022
Form of Restricted Stock Agreement and Grant Notice under Amended and Restated Revance Therapeutics, Inc. 2014 Inducement Plan
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2021
Loan Agreement, dated May 18, 2020, by and between Revance Therapeutics, Inc. and Hint, Inc
Loan Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2020
Indenture, dated as of February 14, 2020, by and between Revance Therapeutics, Inc. and U.S. Bank National Association, as Trustee
Indenture Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2020
Underwriting Agreement, dated December 4, 2019, by and among the Company and the Underwriters
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2019
Underwriting Agreement, dated January 16, 2019, by and among the Company and the Underwriters
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2019
Underwriting Agreement, dated December 6, 2017, by and among the Company, the Selling Stockholders and the Underwriters
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2017
REVANCE THERAPEUTICS, INC. 2014 INDUCEMENT PLAN RESTRICTED STOCK GRANT NOTICE
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2016
REVANCE THERAPEUTICS, INC. 2014 INDUCEMENT PLAN RESTRICTED STOCK GRANT NOTICE
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
REVANCE THERAPEUTICS, INC. 2014 INDUCEMENT PLAN STOCK OPTION GRANT NOTICE
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
3,250,000 Shares Revance Therapeutics, Inc. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2015
REVANCE THERAPEUTICS, INC. $50,000,000 COMMON STOCK SALES AGREEMENT
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2015
REVANCE THERAPEUTICS, INC. WARRANT TO PURCHASE CAPITAL STOCK
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2015
SECOND AMENDMENT TO LOAN AND LEASE AGREEMENT
Loan Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
FIRST AMENDMENT TO LOAN ANDLEASE AGREEMENT
Loan Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
REVANCE THERAPEUTICS, INC. 2014 INDUCEMENT PLAN RESTRICTED STOCK GRANT NOTICE
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
REVANCE THERAPEUTICS, INC. 2014 INDUCEMENT PLAN STOCK OPTION GRANT NOTICE
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
[] Shares Revance Therapeutics, Inc. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2014
WARRANT AGREEMENT To Purchase Shares of Preferred Stock of REVANCE THERAPEUTICS, INC. Dated as of[ ] (the Effective Date)
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
REVANCE THERAPEUTICS, INC. WARRANT TO PURCHASE SHARES OF SERIES PREFERRED STOCK
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
REVANCE THERAPEUTICS, INC. WARRANT TO PURCHASE CAPITAL STOCK
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
REVANCE THERAPEUTICS, INC. WARRANT TO PURCHASE SERIES D PREFERRED STOCK
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
REVANCE THERAPEUTICS, INC. WARRANT TO PURCHASE SHARES OF SERIES PREFERRED STOCK
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
REVANCE THERAPEUTICS, INC. WARRANT TO PURCHASE COMMON STOCK
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
AMENDMENT NO. 2 TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2014
REVANCE THERAPEUTICS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JANUARY 22, 2014 APPROVED BY THE STOCKHOLDERS:JANUARY 23, 2014
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
REVANCE THERAPEUTICS, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT
Investor Rights Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
[] Shares Revance Therapeutics, Inc. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2014
AMENDMENT NO. 1 TO AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT
Investor Rights Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2013
REVANCE THERAPEUTICS, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT
Investor Rights Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2013